In October of this year, a peculiar misstep in the Australian supplement market shed light on the chilly reception that supplement makers continue to face in the world of conventional medicine.
In September, Blackmores—Australia's leading supplement company—made public its partnership with the Pharmacy Guild of Australia—an organization representing 94% of Australia's pharmacies—to introduce a line of four supplements for pairing with pharmaceutical prescriptions. Dubbed the Companion line, the supplements were specially formulated to complement antibiotics and drugs for blood pressure, cholesterol, and gastrointestinal problems. Computer prompts were to remind pharmacists to offer advice on...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more
